These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36335837)

  • 1. A Retrospective Study on Clinical Features of Childhood Moyamoya Disease.
    Wang Y; Kong H; Wang Y; Jin P; Ding J; Li H; Wang H; Zhuo Z
    Pediatr Neurol; 2023 Jan; 138():17-24. PubMed ID: 36335837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nationwide survey on quasi-moyamoya disease in Japan.
    Hayashi K; Horie N; Izumo T; Nagata I
    Acta Neurochir (Wien); 2014 May; 156(5):935-40. PubMed ID: 24499994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
    Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
    J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
    Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial occurrence of moyamoya disease: a clinical study.
    Seol HJ; Wang KC; Kim SK; Hwang YS; Kim KJ; Cho BK
    Childs Nerv Syst; 2006 Sep; 22(9):1143-8. PubMed ID: 16565850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
    Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
    J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and disease progression in moyamoya disease patients with Graves disease.
    Chen JB; Lei D; He M; Sun H; Liu Y; Zhang H; You C; Zhou LX
    J Neurosurg; 2015 Oct; 123(4):848-55. PubMed ID: 25859801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease.
    Chen JB; Liu Y; Zhou LX; Sun H; He M; You C
    J Neurosurg; 2016 May; 124(5):1215-20. PubMed ID: 26406790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
    Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
    Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course of asymptomatic adult moyamoya disease.
    Jo KI; Yeon JY; Hong SC; Kim JS
    Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Clinical and Radiographic Phenotypes in Pediatric Patients With Moyamoya.
    Kaseka ML; Slim M; Muthusami P; Dirks PB; Westmacott R; Kassner A; Bhathal I; Williams S; Shroff M; Logan W; Moharir M; MacGregor DL; Pulcine E; deVeber GA; Dlamini N
    Pediatr Neurol; 2021 Jul; 120():18-26. PubMed ID: 33962345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of moyamoya disease with Graves' disease: a retrospective study of 394,422 patients with thyroid disease.
    Hiruma M; Watanabe N; Mitsumatsu T; Suzuki N; Fukushita M; Matsumoto M; Yoshihara A; Yoshimura Noh J; Sugino K; Ito K
    Endocr J; 2023 Feb; 70(2):141-148. PubMed ID: 36198616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.
    Zhang Y; Bao XY; Duan L; Yang WZ; Li DS; Zhang ZS; Han C; Zhao F; Zhang Q; Wang QN
    J Neurosurg Pediatr; 2018 Aug; 22(2):173-180. PubMed ID: 29856299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features, surgical treatment, and long-term outcomes of moyamoya disease in a single institution of Fujian, Southeast China: A retrospective study.
    Ding YH; Chen JY; Zheng ES; Wang ZQ; Liang RS; Shi SS; Tu XK
    Medicine (Baltimore); 2023 Oct; 102(43):e35684. PubMed ID: 37904447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of seasonal variations on the first ischemic events in patients with moyamoya disease.
    Ding J; Zhou D; Shang S; Pan L; Ya J; Ding Y; Ji X; Meng R
    Clin Neurol Neurosurg; 2018 Oct; 173():65-69. PubMed ID: 30089245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment.
    Kim SK; Seol HJ; Cho BK; Hwang YS; Lee DS; Wang KC
    Neurosurgery; 2004 Apr; 54(4):840-4; discussion 844-6. PubMed ID: 15046649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac manifestations in a western moyamoya disease population: a single-center descriptive study and review.
    Larson AS; Savastano L; Klaas J; Lanzino G
    Neurosurg Rev; 2021 Jun; 44(3):1429-1436. PubMed ID: 32507930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-Phenotype Correlation in Long-Term Cohort of Japanese Patients with Moyamoya Disease.
    Nomura S; Yamaguchi K; Akagawa H; Kawashima A; Moteki Y; Ishikawa T; Aihara Y; Saito T; Okada Y; Kawamata T
    Cerebrovasc Dis; 2019; 47(3-4):105-111. PubMed ID: 30947170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nationwide survey on unilateral moyamoya disease in Japan.
    Hayashi K; Horie N; Izumo T; Nagata I
    Clin Neurol Neurosurg; 2014 Sep; 124():1-5. PubMed ID: 24976021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.